This trial is evaluating whether Route 92 Medical Reperfusion System will improve 2 primary outcomes in patients with Stroke, Acute, Stroke Ischemic. Measurement will happen over the course of During procedure.
This trial requires 220 total participants across 2 different treatment groups
This trial involves 2 different treatments. Route 92 Medical Reperfusion System is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"A stroke event is characterized by a set of clinical signs of stroke. These signs include weakness or numbness in the area of the stroke and loss of consciousness." - Anonymous Online Contributor
"Clinical trials for acute stroke should focus on prevention protocols; as of 2002, there has still not been a significant shift in the research toward stroke prevention. If the goal of stroke prevention is to produce a better quality of life, then more money should be allocated for research on the neurological and other long-term results of stroke, including the cognitive and functional outcome of stroke patients." - Anonymous Online Contributor
"Symptoms, acute brain damage on cerebral MRI, and family history do NOT indicate ischemic cerebral stroke. Other factors in this population might include a high-risk profile of depression, hypertension, and elevated homocysteine levels all associated with ischemic stroke." - Anonymous Online Contributor
"The burden of stroke is heavy in the U.S. with the prevalence of stroke ischemic being about 10 times higher than that of CAD. We must prepare for and invest in a comprehensive strategy to reduce the morbidity and mortality of stroke and stroke ischemic." - Anonymous Online Contributor
"Stroke is the most common cause of a neurological deficit in adulthood. About 10% of the general population experienced a stroke in 2010. The incidence of stroke among the population is likely to increase in future due to lifestyle factors. The major risk factors for stroke are the usual cardiovascular risk factors. It was evident that cardio-cerebro-vascular diseases are being recognized in the modern era due to increased usage of imaging technology." - Anonymous Online Contributor
"What are common treatments for acute stroke ischemia are aspirin and thrombolytic agents such as tissue plasminogen activator and enoxaparin. Patients that have acute stroke ischemic are treated with aspirin, anticoagulants (aspirin-warfarin combination), antiplatelets, and NSAIDs and antihyperglycemia (metformin/glipizide) are often prescribed. These treatments are also effective on improving functionality for these patients." - Anonymous Online Contributor
"The development of modern magnetic resonance imaging (MRI) devices has brought some new possibilities of treatments for acute stroke, acute ischemic stroke, and for recovery (including rehabilitation) after the brain is damaged from a stroke." - Anonymous Online Contributor
"The route 92 system in recent years has come a great advance, and we think that this system will be universally used, as it can be easily used by the clinical technicians at all levels, and more so than conventional systems." - Anonymous Online Contributor
"About 10% of patients who have an ischemic stroke die within 30 days, and the risk of stroke death increases threefold after the first 90 days after onset. The overall risk of stroke death is about 5%--about 3% by 90 days and about 2% by 190 days." - Anonymous Online Contributor
"It was found that stroke was caused primarily by atherosclerosis. The number of affected women increased as both the age and the number of children increased, because the time taken to conceive children increased as well." - Anonymous Online Contributor
"In this patient sample, only the presence of stroke complaints in conjunction with a history of previous stroke was associated with a higher likelihood of benefiting from clinical trials. This suggests that patients with a history of stroke should be considered candidates for clinical trials as the condition of their stroke might be related to the treatment being tested. Clinical trial programs should also consider the availability of such patients in their geographic region to ensure equitable treatment allocation." - Anonymous Online Contributor
"The medical reperfusion system using the SENTI protocol, after previous trials in acute limb ischemia, is a useful treatment during percutaneous coronary intervention. This therapy may delay or even increase mortality, even after a successful stent implantation." - Anonymous Online Contributor